Zaggle reported a net profit of INR 35 Cr in Q2 FY26, up 72% YoY from INR 20.3 Cr in Q2 FY25 and 34% higher on a sequential ...

The autologous CAR-T cell therapy MB-105 has received regenerative medicine advanced therapy (RMAT) designation from the FDA ...

Q3 2025 Management View CEO Zack Arnold highlighted "exceptional results that demonstrate our continued momentum across the ...

Solicitor General D. John Sauer withdraws request that US Supreme Court halt R.I. judge’s order “because the underlying ...

Scholarships are essential for making business education more accessible. Learn how a full fee waiver reshaped one MBA student’s path ...

Infinity Natural Resources Inc (INR) reports a 39% production increase and strategic land acquisitions, while navigating market uncertainties and capital expenditure challenges.

AnaptysBio plans to advance rosnilimab for RA, with a program update expected in the first half of 2026. Read why ANAB stock ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsJay Short - Co-Founder, CEO & ChairmanSheri Lydick - ...

A booming electrical apprenticeship program is offering structure, mentorship and purpose to young men. There is a growing need for such solutions.

Detailed price information for Infinity Natural Resources Inc Cl A (INR-N) from The Globe and Mail including charting and trades.

The ASX healthcare sector finished the week in a steady state, despite ripple effects of a sharp sell-off on Wall Street.